Linardos, Akis
Kushibar, Kaisar
Walsh, Sean
Gkontra, Polyxeni
Lekadir, Karim
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme (952103)
European Union’s Horizon 2020 research and innovation programme (952103)
European Union’s Horizon 2020 research and innovation programme (952103)
European Union’s Horizon 2020 research and innovation programme (952103)
Article History
Received: 5 July 2021
Accepted: 2 February 2022
First Online: 3 March 2022
Competing interests
: Sean Walsh declares the following financial interests/personal relationships which may be considered as potential competing interests: within and outside the submitted work, is the recipient of grants/sponsored research agreements in the areas of medical imaging, artificial intelligence, data science, applied to the clinical specialties of oncology and respiratory medicine. He holds a leadership position within Oncoradiomics SA, has shares in the company Oncoadiomics SA, and is co-inventor of submitted patents on behalf Oncoradiomics SA. The rest of the authors declare no competing interests.